Insulin-Like Growth Factor-1 Decreases Sympathetic Nerve Activity: The Effect Is Modulated by Glycemic Status

Experimental Biology and Medicine

Volumn 216, Issue 1, 1997, Pages 93-97

  Duanmu, Zhengbo ^a   Lapanowski, Karen ^a   Dunbar, Joseph C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HYPERINSULINEMIA; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SYMPATHETIC NERVE;

ANIMALS; BLOOD GLUCOSE; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; LUMBOSACRAL REGION; MALE; RATS; RATS, WISTAR; SYMPATHETIC NERVOUS SYSTEM;

ANIMALIA;

EID: 0030931999     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Zackenfeis K, Oppenheim RW, Rohrer H. Evidence for an important role of IGF-I and IGF-II for the early development of chick sympathetic neurons. Neuron 14:731-741, 1995.
2. Stewart CE, Rotwein P. Growth differentiation and survival: Multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005-1026, 1996.
3. Binoux M. The IGF system in metabolism regulation. Diabete Metab 21:330-337, 1995.
4. Rindernecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor 1 and its structural homology with proinsulin. J Biol Chem 253:2769-2776, 1978.
5. Motham CP, Duronio V, Jacobs S. Insulin like growth factor 1 receptor B-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin like growth factor-1 and insulin receptor heterodimers. J Biol Chem 264:13238-13244, 1989.
6. Fryburg DA. Insulin-like growth factor-1 exerts growth hormone and insulin-like action on human muscle protein metabolism. Am J Physiol 267:E331-E336, 1994.
7. Lewitt MS. Role of insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Res Clin Pract 23:3-15, 1994.
8. Chatham TD, Holly JM, Clayton K, Cwyfan-Hughes S, Dunger DB. The effects of repeated daily recombinant human insulin-like growth factor 1 administration in adolescents with type-1 diabetes. Diabet Med 12:885-892, 1995.
9. Pete G, Hu Y, Walsh MF, Sowers J, Dunbar JC. IGF-I decreases mean blood pressure and selectively increases regional blood flow in normal rats. Proc Soc Exp Biol Med 213:187-192, 1996.
10. Hu Y, Pete G, Walsh MF, Sowers J, Dunbar JC. Central IGF-I decreases systemic blood pressure and increases blood flow in selective vascular beds. Horm Metab Res 28: 211-214, 1996.
11. Wright-Richey J, Schultz-Klarr S, Dunbar JC. The effect of ventral medial hypothalamic lesion on the insulin induced hypotensive response in normal rats. Acta Diabetol 31:91-97, 1994.
12. Baron AD. Hemodynamic action of insulin. Am J Physiol 267: E187-E202, 1994.
13. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252, 1991.
14. Anderson EA, Mark AL. Vasodilator action of insulin: Implication for the insulin hypothesis of hypertension. Hypertension 21:136-141, 1993.
15. Valiquette M, Parent S, Loisel TP, Bouvier M. Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylations and increased responsiveness of the huamn beta-2 adrenergic receptor. EMBO J 14:5542-5549, 1995.
16. Rowe JW, Young JB, Minoker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusion on sympathetic nervous system activity in normal man. Diabetes 30:219-225, 1981.
17. Berne C, Fagius J, Pallore T, Hjemdahl P. The sympathetic response to euglycemic hyperinsulinemia. Evidence from microelectrode nerve recording in healthy subjects. Diabetologia 35:873-879, 1992.
18. Carlsson S, Skarphedinsson JO, Delie M, Hoffman P, Thoren P. Differential responses in post- and pre-ganglionic adrenal sympathetic nerve activity and renal sympathetic nerve activity after injection of 2-deoxy-D-glucose and insulin in rats. Acta Physiol Scand 145:169-175, 1992.
19. Havel PJ, Mundinger TO, Taborsky GJ. Pancreatic sympathetic nerves contribute to increased glucagon secretion during severe hypoglycemia in dogs. Am J Physiol 270:E20-E26, 1996.
20. Schreihofer AM. Use of sinoaortic denervation to study the role of baroreceptors in cardiovascular regulation. Am J Physiol 266: R1705-R1710, 1994.
21. McKillop I, Haylor J, el Nahas AM. IGF-I stimulates renal function in the isolated kidney: Inhibition by aminoguanidine and nitroarginine methyl ester. Exp Nephrol 3:49-57, 1995.
22. Jaffa AA, LeRoith D, Roberts CT Jr., Rust PF, Mayfield RK. Insulin- like growth factor 1 produces renal hyperfiltration by a kinn-mediated mechanism. Am J Physiol 266:F102-F107, 1994.
23. Schultz-Klarr S, Wright-Richey J, Dunbar JC. Plasma glucose, insulin and cardiovascular responses after intravenous and intracerebroventricular injections of insulin, 2-deoxyglucose and glucose in rats. Diabetes Res Clin Pract 26:81-89, 1994.
24. Muntzel MS, Anderson AE, Johnson AK, Mark AL. Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 17:39-50, 1995.
25. Baura GD, Foster DM, Porte D Jr., Kahn SE, Bergman RN, Cobelli C, Schwartz MW. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. J Clin Invest 92:1824-1830, 1993.
26. Van Houten M, Posner BI, Kopriwa BM, Brawer JR. Insulin binding sites in the rat brain: In vivo localization to the circumventricular organs by quantitative radioautography. Endocrinology 105:666-673, 1979.
27. Vollenweider P, Tappy L, Randin D, Schneider P, Jequier E, Nicod P, Scherrer U. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92:147-154, 1993.
28. Freestone NS, Ribaric S, Mason WT. The effect of insulin like growth factor 1 on adult rat cardiac contractility. Mol Cell Biochem 164:223-229, 1996.